FDA Adverse Event Injury Summary report: N

BINAXNOW COVID-19 AG SELF TEST

MDR report key: 12651606 · Received October 18, 2021

Report

Report Number
1221359-2021-03118
Event Type
Injury
Date Received
October 18, 2021
Date of Event
September 24, 2021
Report Date
April 25, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
PMA / PMN Number
EUA210264
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION REPORT: ACCORDING TO THE PACKAGE INSERT IN195000 V. 3.0: PRECAUTIONS 21. THE EXTRACTION REAGENT PACKAGED IN THIS KIT CONTAINS SALINE, DETERGENTS AND PRESERVATIVES THAT WILL INACTIVATE CELLS AND VIRUS PARTICLES. SAMPLES ELUTED IN THIS SOLUTION ARE NOT SUITABLE FOR CULTURE. BASED ON THE ABOVE SUMMARY, THE INVESTIGATION IS DEEMED COMPLETE. THE PRODUCT WILL CONTINUE TO BE MONITORED AND TRACKED.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION. THE CONSUMER'S FRIEND WAS PROVIDED WITH THE EXTRACTION REAGENT SAFETY DATA SHEET (SDS) AND ADVISED TO HAVE THE CONSUMER CONSULT WITH THEIR DOCTOR.

Description of Event or Problem · 1

THE CONSUMER'S FRIEND REPORTED THE CONSUMER ACCIDENTLY USED THE BINAXNOW COVID-19 EXTRACTION REAGENT FROM THE SELF-TEST IN HER EYES. IT WAS ALSO REPORTED THE CONSUMER EXPERIENCED EYE IRRITATION DUE TO THIS EVENT. ALTHOUGH REQUESTED, ADDITIONAL INFORMATION WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1547374 BINAXNOW COVID-19 AG SELF TEST LATERAL FLOW IMMUNOASSAY IVD COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC.

Patients

Seq Age Sex Outcome Treatment
1 Female Other